In the ever-evolving landscapeof healthcare, Circular Genomics, a private company that just closed a $8.3MMSeries A round earlier this year, stands out as a trailblazer in the pursuit ofprecision medicine in psychiatry. Co-founded by Dr. Nikoloas Mellios, aneuroscientist and former physician, the company is leveraging innovativebiomarkers to transform the diagnosis and treatment of psychiatric disorders.